These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31303272)

  • 1. Soluble UL16-binding protein 2 is associated with a poor prognosis in pancreatic cancer patients.
    Kegasawa T; Tatsumi T; Yoshioka T; Suda T; Ikezawa K; Nakabori T; Yamada R; Kodama T; Shigekawa M; Hikita H; Sakamori R; Takehara T
    Biochem Biophys Res Commun; 2019 Sep; 517(1):84-88. PubMed ID: 31303272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
    J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
    Cho H; Chung JY; Kim S; Braunschweig T; Kang TH; Kim J; Chung EJ; Hewitt SM; Kim JH
    BMC Cancer; 2014 Dec; 14():957. PubMed ID: 25510288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell-mediated shedding of ULBP2.
    Wang R; Sun PD
    PLoS One; 2014; 9(3):e91133. PubMed ID: 24614922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.
    Li K; Mandai M; Hamanishi J; Matsumura N; Suzuki A; Yagi H; Yamaguchi K; Baba T; Fujii S; Konishi I
    Cancer Immunol Immunother; 2009 May; 58(5):641-52. PubMed ID: 18791713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
    Fernández-Messina L; Ashiru O; Agüera-González S; Reyburn HT; Valés-Gómez M
    J Cell Sci; 2011 Feb; 124(Pt 3):321-7. PubMed ID: 21224393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study.
    Lee GH; An HJ; Kim TH; Kim G; Park KS; Park H; Lee TH; Kwon AY
    Yonsei Med J; 2021 Apr; 62(4):288-297. PubMed ID: 33779082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic impact of serum-soluble UL16-binding protein 2 in lung cancer patients.
    Yamaguchi K; Chikumi H; Shimizu A; Takata M; Kinoshita N; Hashimoto K; Nakamoto M; Matsunaga S; Kurai J; Miyake N; Matsumoto S; Watanabe M; Yamasaki A; Igishi T; Burioka N; Shimizu E
    Cancer Sci; 2012 Aug; 103(8):1405-13. PubMed ID: 22587355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein.
    Lin X; Huang M; Xie F; Zhou H; Yang J; Huang Q
    Oncotarget; 2016 Oct; 7(43):70092-70099. PubMed ID: 27602753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.
    Tsukagoshi M; Wada S; Yokobori T; Altan B; Ishii N; Watanabe A; Kubo N; Saito F; Araki K; Suzuki H; Hosouchi Y; Kuwano H
    Cancer Sci; 2016 Feb; 107(2):116-22. PubMed ID: 26608587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.
    Fujita H; Hatanaka Y; Sutoh Y; Suzuki Y; Oba K; Hatanaka KC; Mitsuhashi T; Otsuka N; Fugo K; Kasahara M; Matsuno Y
    J Histochem Cytochem; 2015 Mar; 63(3):217-27. PubMed ID: 25473094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I; Steinle A
    Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
    Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection.
    Chang YT; Wu CC; Shyr YM; Chen TC; Hwang TL; Yeh TS; Chang KP; Liu HP; Liu YL; Tsai MH; Chang YS; Yu JS
    PLoS One; 2011; 6(5):e20029. PubMed ID: 21625447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
    Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; Garay MCG; Suarez-Alvarez B; Lopez-Larrea C
    Oncotarget; 2017 May; 8(19):31959-31976. PubMed ID: 28404876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients.
    Mou X; Zhou Y; Jiang P; Zhou T; Jiang Q; Xu C; Liu H; Zheng T; Yuan G; Zhang Y; Chen D; Mao C
    Sci Rep; 2014 Aug; 4():6138. PubMed ID: 25138242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
    Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R
    Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
    Cosman D; Müllberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ
    Immunity; 2001 Feb; 14(2):123-33. PubMed ID: 11239445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D.
    Song H; Park H; Park G; Kim YS; Lee HK; Jin DH; Kang HS; Cho DH; Hur D
    Oncol Rep; 2014 Jul; 32(1):425-30. PubMed ID: 24841552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.